Welcome to our dedicated page for Centene Del news (Ticker: CNC), a resource for investors and traders seeking the latest updates and insights on Centene Del stock.
Centene Corporation (NYSE: CNC), a leading provider of government-sponsored healthcare programs, offers investors and stakeholders timely access to its latest developments through this centralized news hub. Track official press releases, regulatory filings, and strategic initiatives from the Fortune 500 company driving innovation in Medicaid managed care and Medicare Advantage plans.
This resource delivers essential updates including quarterly earnings reports, contract awards with state/federal agencies, partnerships advancing telehealth services, and expansions of behavioral health programs. Users will find verified information on Centene’s specialty services like pharmacy benefits management and corrections healthcare solutions.
Bookmark this page for direct access to CNC’s:
• Annual and quarterly financial performance
• Government program enrollment updates
• Strategic acquisitions in healthcare services
• Regulatory compliance milestones
Monitor Centene’s progress in addressing healthcare disparities through its integrated care models and value-based initiatives. Return regularly for unfiltered updates directly from corporate communications and SEC filings.
Centene Corporation (NYSE: CNC) has withdrawn its previously issued 2025 GAAP and adjusted diluted earnings per share (EPS) guidance due to significant challenges in its Health Insurance Marketplace business and Medicaid operations.
Based on data from Wakely covering 22 of 29 Marketplace states, CNC expects a reduction of approximately $1.8 billion in net risk adjustment revenue transfer, corresponding to an adjusted diluted EPS impact of about $2.75. The company anticipates additional reductions from the remaining seven states. In response, Centene has begun refiling 2026 Marketplace rates to reflect higher projected baseline morbidity.
The company's Medicaid business is experiencing increased medical cost trends in behavioral health, home health, and high-cost drugs, particularly in New York and Florida. The Q2 2025 Medicaid Health Benefits Ratio is expected to be higher than Q1. On a positive note, Medicare Advantage and Medicare Prescription Drug Plan businesses are performing above expectations, and the company continues to achieve strong SG&A expense leverage.
Superior HealthPlan, a subsidiary of Centene (NYSE: CNC), has awarded $200,000 in grants to 20 community-based organizations and healthcare providers across Texas. The funding, distributed through their annual grant program, aims to address healthcare barriers and non-medical drivers of health in low-income communities.
The grants are split between 10 community organizations and 10 healthcare providers, each receiving funding for specific projects ranging from diaper distribution programs to medical equipment purchases. Notable recipients include Her Pantry in El Paso, YMCA of Greater San Antonio, and various healthcare facilities across Texas.
Since 2020, Superior has invested over $940,000 through this grant program, supporting initiatives focused on food access, economic stability, healthcare, housing, education, and other critical needs affecting overall health and well-being.
Meridian Health Plan of Illinois, a Centene (NYSE: CNC) company, has announced a partnership with farmers markets across central and southern Illinois to combat food insecurity in 2025. The initiative offers vouchers for fresh produce purchases, with Meridian members receiving $15 in vouchers and non-members receiving $10 per market visit.
The program includes a SNAP/Link benefit doubling feature, where $25 in SNAP benefits converts to $50 for fresh produce purchases. Building on their successful 2024 pilot at Carbondale, which distributed 540 vouchers worth over $3,750 to 321 attendees, the program will expand to multiple locations including Carbondale, Champaign, Murphysboro, Marion, Anna-Jonesboro, and East St. Louis between May and September 2025.
Delaware First Health (DFH) and the Centene Foundation have announced a grant program targeting social drivers of health in Delaware. The initiative will distribute $500,000 in grants over three years, with individual grants starting at $10,000. Applications are open to Delaware-based 501c3 organizations serving the Medicaid population, with submissions accepted through June 13, 2025.
The program prioritizes projects addressing housing instability and transportation accessibility, though applications targeting other social health drivers will be considered. Organizations must demonstrate measurable outcomes and impact over time. Award announcements are scheduled for July 2025.
National Veterinary Associates (NVA) has announced key board appointments ahead of its planned IPO, naming Ken Burdick as Executive Chairman and Dr. Mike McFarland as Director. Burdick brings over 40 years of healthcare experience and currently serves as Executive Chairman at LifeStance Health (NASDAQ: LFST). He previously led WellCare Health Plans as CEO, delivering strong performance in revenue and profit margins before its acquisition by Centene Corporation.
Dr. McFarland contributes more than 40 years of veterinary healthcare expertise, including 11 years in senior leadership at Zoetis, Inc. and previous roles at Pfizer Animal Health. Greg Hartmann will remain on the board as a director, maintaining his investment in the company.